StockData
Bio Essence Corp logo

Bio Essence Corp (BIOE) stock

BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$0.42+0.03 (+7.72%)

Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –

Bio Essence cash

Cash and short-term investments held at the end of each period.

Bio Essence's cash was $201.51K at Sep 30, 2026. For fiscal 2024 it was $1.37K, up 1102.6% from the year before. The highest annual figure on record is $16.16K in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2024Dec 31, 2024$1.37K+1102.6%
FY2023Dec 31, 2023$114-98.2%
FY2022Dec 31, 2022$6.26K+1966.7%
FY2021Dec 31, 2021$303-94.3%
FY2020Dec 31, 2020$5.33K-67.1%
FY2019Dec 31, 2019$16.16K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$201.51K+14598.1%
Q2 FY2026Jun 30, 2026$675-97.7%
Q1 FY2026Mar 31, 2026$36.18K+281.3%
Q3 FY2025Sep 30, 2025$28.74K+124860.9%
Q4 FY2024Dec 31, 2024$1.37K+1102.6%
Q3 FY2024Sep 30, 2024$29.82K+33403.4%
Q2 FY2024Jun 30, 2024$9.49K+1654.0%
Q1 FY2024Mar 31, 2024$23-81.9%
Q4 FY2023Dec 31, 2023$114-98.2%
Q3 FY2023Sep 30, 2023$89-84.4%
Q2 FY2023Jun 30, 2023$541+347.1%
Q1 FY2023Mar 31, 2023$127-43.6%
Q4 FY2022Dec 31, 2022$6.26K+1966.7%
Q3 FY2022Sep 30, 2022$572-97.9%
Q2 FY2022Jun 30, 2022$121-98.5%
Q1 FY2022Mar 31, 2022$225-97.8%
Q4 FY2021Dec 31, 2021$303-94.3%
Q3 FY2021Sep 30, 2021$26.71K+5407.8%
Q2 FY2021Jun 30, 2021$8.22K-90.3%
Q1 FY2021Mar 31, 2021$10.26K+3.9%
Q4 FY2020Dec 31, 2020$5.33K-67.1%
Q3 FY2020Sep 30, 2020$485–
Q2 FY2020Jun 30, 2020$84.33K–
Q1 FY2020Mar 31, 2020$9.87K–
Q4 FY2019Dec 31, 2019$16.16K–

More Bio Essence figures

See a number that looks wrong?